Related references
Note: Only part of the references are listed.Biowaiver monographs for immediate release solid oral dosage forms: Efavirenz
Rodrigo Cristofoletti et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A case study on the in silico absorption simulations of levothyroxine sodium immediate-release tablets
Ivana Kocic et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
In Vitro-In Vivo Correlation for Gliclazide Immediate-Release Tablets Based on Mechanistic Absorption Simulation
Sandra Grbic et al.
AAPS PHARMSCITECH (2011)
In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype
Dinko Rekic et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development Current Status and Future Directions
Olavi Pelkonen et al.
CLINICAL PHARMACOKINETICS (2011)
New Solid State Forms of the Anti-HIV Drug Efavirenz. Conformational Flexibility and High Z′ Issues
Sudarshan Mahapatra et al.
CRYSTAL GROWTH & DESIGN (2010)
The Biowaiver Extension for BCS Class III Drugs: The Effect of Dissolution Rate on the Bioequivalence of BCS Class III Immediate-Release Drugs Predicted by Computer Simulation
Yasuhiro Tsume et al.
MOLECULAR PHARMACEUTICS (2010)
Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility
Christaâ E. Müller
CHEMISTRY & BIODIVERSITY (2009)
A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry
Dimple Pabla et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products
Arthur Okumu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Efavirenz: a decade of clinical experience in the treatment of HIV
Franco Maggiolo
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Justification of Biowaiver for Carbamazepine, a Low Soluble High Permeable Compound, in Solid Dosage Forms Based on IVIVC and Gastrointestinal Simulation
Ivan Kovacevic et al.
MOLECULAR PHARMACEUTICS (2009)
Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds
Marija Tubic-Grozdanis et al.
AAPS JOURNAL (2008)
Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling
Filippos Kesisoglou et al.
AAPS JOURNAL (2008)
Physicochemical characterization of five glyburide powders:: A BCS based approach to predict oral absorption
Hai Wei et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; Prediction from a miniscale dissolution test and a physiologically-based computer simulation
Ryusuke Takano et al.
PHARMACEUTICAL RESEARCH (2008)
Dynamic Dissolution Testing To Establish In Vitro/In Vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug
Arthur Okumu et al.
PHARMACEUTICAL RESEARCH (2008)
Current perspectives in dissolution testing of conventional and novel dosage forms
Shirzad Azarmi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Biorelevant dissolution media as a predictive tool for glyburide a class II drug
Hai Wei et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test
Ryusuke Takano et al.
PHARMACEUTICAL RESEARCH (2006)
Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets
D Desai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Feasibility of biowaiver extension to Biopharmaceutics Classification System Class III drug products - Cimetidine
E Jantratid et al.
CLINICAL PHARMACOKINETICS (2006)
Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation
ZG He et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification
Nehal A. Kasim et al.
MOLECULAR PHARMACEUTICS (2004)
Identification of biowaivers among class II drugs: Theoretical justification and practical examples
E Rinaki et al.
PHARMACEUTICAL RESEARCH (2004)
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
M Lindenberg et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects
R DiCenzo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS clinical trial group study 398
M Pfister et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
